Owner MediGene AG

Inventors Buning, Hildegard; Huttner, Nadja; Ried, Martin; Hallek, Michael; Enssle, Jorg; Perabo, Luca

Agent Watermark

Pub. Number AU-B-2002352261

PCT Number PCT/EP02/14750

PCT Pub. Number WO2003/054197

Priority 60/362,349 07.03.02 US; 60/344,131 21.12.01 US; 60/407,116 30.08.02 US

Filing date 23 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 7 February 2008

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/01 (2006.01) Peptides having more than 20 amino acids

C07K 14/015 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/33 (2006.01) Mutation or genetic engineering - Genes encoding viral proteins

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids